Stockreport

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo [Yahoo! Finance]

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com
PDF TEV-‘408 is currently in Phase 1b for treatment of vitiligo and in Phase 2a for celiac disease Funding agreement supports Teva's Pivot to Growth strategy to accelerat [Read more]